| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026255 |
| Receipt No. | R000030082 |
| Official scientific title of the study | A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery |
| Date of disclosure of the study information | 2017/02/22 |
| Last modified on | 2019/02/25 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery | |
| Title of the study (Brief title) | A randomized controlled trial of reducing effect of postoperative epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendscopic surgery | |
| Region |
|
|
| Condition | ||
| Condition | lumbar spinal canal stenosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the reducing effect of postopertive epidural haematoma formation by the use of gelatin hemostatic matrix with human thrombin (FloSeal) in cases with lumbar spinal canal stenosis treated by microendoscopic surgery |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | quantity of postoperative drainage at 36 hours after surgery |
| Key secondary outcomes | numerical rating scale(NRS) of postoperative leg pain
size of area of haematoma on the axial image of MRI examined a few days after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | When decompression procedure is finished and operation of hemostasis is completed in microendoscopic spinal surgery, surgeon is told whether the patient belongs to a group of FloSeal or control. If a FloSeal group, FloSeal (5ml) is applied to around dura. After then, drainage is put in surgical field and surgical procedure is finished. | |
| Interventions/Control_2 | When decompression procedure is finished and operation of hemostasis is completed in microendoscopic spinal surgery, surgeon is told whether the patient belongs to a group of FloSeal or control. If a control group, drainage is put in surgical field and surgical procedure is finished. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with lumbar spinal canal stenosis who undergo microendoscopic spinal surgery in our hospital | |||
| Key exclusion criteria | Patients who have hemorrahagic factors (hemodialysis, liver cirrhosis, etc)
Patients of foraminal stenosis Patients of re-operation Patients who suffer dural tear intraoperatively Patients whose drainage is put unsuitably Patients who are thought that use of FloSeal is mandatory because of difficulty of hemostasis in the surgical field Others who are inadequate to current study |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Masanari Takami |
| Organization | Wakayama Medical University |
| Division name | Department of orthopaedic surgery |
| Address | 811-1 Kimiidra, Wakayama, Japan |
| TEL | 073-441-0645 |
| maatomo324@gmail.com | |
| Public contact | |
| Name of contact person | Masanari Takami |
| Organization | Wakayama Medical University |
| Division name | Department of orthopaedic surgery |
| Address | 811-1 Kimiidra, Wakayama, Japan |
| TEL | 073-441-0645 |
| Homepage URL | |
| maatomo324@gmail.com | |
| Sponsor | |
| Institute | Department of orthopaedic surgery, Wakayama Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030082 |